Mintal Tracker Wins Highest Honor From Prestigious 2022 Fall Digital Health Awards
The award-winning app uses AI to monitor and help users achieve healthier sleep SUNNYVALE, Calif., Nov. 29, 2022 /PRNewswire/ -- Mintal Tracker, a sleep tracking app driven by artificial intelligence (AI) technology that offers a scientific approach to healthier sleep, received a 2022 Gold Award in the Mobile Application category of the Fall session of the 24th annual...
Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution
The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, Nov. 29, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the US clinical decision support for the critical care industry and, based on its findings, recognizes Etiometry with the 2022 US Clinical Decision Support market...
A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, received IND clearance from NMPA for clinical trial
NANJING, China, Nov. 29, 2022 /PRNewswire/ -- Buchang Biopharmaceutical and REMD Biotherapeutics, partners of GenScript ProBio, recently received IND approval of BC008-1A from China NMPA for Phase 1 clinical trial. BC008-1A (NMPAIND number: CXSL2200315), a bispecific antibody drug co-targeting the immune checkpoints PD-1 and TIGIT, for treatment of patients with advanced solid tumors....
TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife® Satylia® in Germany
PARIS, Nov. 29, 2022 /PRNewswire/ -- TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® Satylia® in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. SymbioLife® Satylia® is a precision probiotic with a characterized mechanism of...
Building a Fitness Community: KL Wellness City Fitness Fiesta Offers Free and Fun Activities for All, Sponsors Staff to IRONMAN Western Australia
KUALA LUMPUR, Malaysia, Nov. 29, 2022 /PRNewswire/ -- KL Wellness City Sdn Bhd, the visionary developer of Southeast Asia's first 360-degree integrated wellness hub, continues its effort to empower the community towards a healthier lifestyle by launching the first ever Fitness Fiesta, which is set to be held in December 2022. Building a Fitness...
Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment
SEOUL, South Korea, Nov. 29, 2022 /PRNewswire/ -- At the World Congress for Hair Research 2022 (Melbourne, Australia), Yuyu Pharma shared its plans to conduct clinical trials in the U.S. and Europe for its Dutasteride Tablet ("DUT") for the treatment of Androgenetic Alopecia ("AGA"). Robert Yu, CEO of Yuyu Pharma is presenting at the...
Probiotic strain SNZ 1969® helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows
HYDERABAD, India, Nov. 29, 2022 /PRNewswire/ -- Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969® (Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as...
AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivered strong financial results. Aroa reports a strong cash balance...
Cambridge Cognition and Luca Healthcare Announce a Strategic Partnership and an Exclusive Licensing Agreement to Commercialize Cambridge Cognition’s Suite of Cognitive Assessment Tools and Brain Health Products for the...
SHANGHAI, Nov. 29, 2022 /PRNewswire/ -- Cambridge Cognition, a leading technology company, which develops and markets digital solutions to assess brain health, and Luca Healthcare, China's category leader in developing and commercializing clinically validated digital health solutions, today announces a strategic partnership and a 10-year exclusive licensing agreement to commercialize Cambridge Cognition's suite of cognitive assessment tools in the China market. ...
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform BRUSSELS and WATCHUNG, N.J. and SHANGHAI, Nov. 29, 2022 /PRNewswire/ -- Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced an agreement to acquire New Jersey-based Focus-X Therapeutics, a company developing targeted radiopharmaceuticals to treat cancer based on proprietary peptide engineering...
